A newly documented case in The New England Journal of Medicine brings attention to an often-underrecognized complication of long-term immunosuppressive therapy: peripheral T-cell lymphoma in organ transplant recipients. While immunosuppression remains essential for preventing organ rejection, it simultaneously creates conditions that may permit malignant T-cell transformation.
The reported patient presented with nonspecific symptoms including fatigue, weight loss, and lymphadenopathy before comprehensive diagnostic workup confirmed peripheral T-cell lymphoma through histological and molecular analysis. This case underscores the critical need for expanded cancer surveillance protocols beyond the traditionally monitored malignancies in transplant populations.
Clinicians managing transplant recipients must maintain heightened awareness of secondary malignancy risks and implement multidisciplinary approaches to early detection and treatment. The complexity of balancing immunosuppression necessity with malignancy risk requires ongoing clinical vigilance and refined monitoring strategies.
Read the full article on GMJ Newsroom.
Was this article helpful?
